Gene · 9733
Papers1,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance. | iScience | 2026 | 42221825 | PubTator, text mining | PubMed |
| A bioinformatics pipeline for the design of a SART3-targeted cancer vaccine with enhanced immunogenicity. | Genomics Inform | 2026 | 42067955 | PubTator, text mining | PubMed |
| LncRNA LASTR promotes TGF-β signalling and EMT in HNSCC by enhancing TGFβR1 expression by suppressing biogenesis of miR-34a and acting as its ceRNA. | Cell Signal | 2026 | 41812719 | PubTator, text mining | PubMed |
| Rabies lyssavirus phosphoprotein possesses RNA duplex-unwinding activities. | Mol Ther Nucleic Acids | 2026 | 41783789 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
| TIE2-positive cells in the nucleus pulposus with a purpose: the who, what and why. | J Biomed Sci | 2026 | 41772594 | PubTator, text mining | PubMed |
| Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2. | Molecules | 2026 | 41752399 | PubTator, text mining | PubMed |
| Advances in Breast Cancer Research: Immunological, Pathological, and Pharmacological Perspectives for Improving Patient Outcomes. | Int J Mol Sci | 2026 | 41752040 | PubTator, text mining | PubMed |
| Identification of two novel MVD mutations and one novel FDPS mutation in Chinese patients with porokeratosis. | Front Med (Lausanne) | 2026 | 41737384 | PubTator, text mining | PubMed |
| Advances in T cell-based immunotherapy for osteosarcoma. | Front Immunol | 2026 | 41727478 | PubTator, text mining | PubMed |
| Inference of Genetic Networks from Pseudo Time Series of Single-cell Gene Expression Data using Modified Random Forests. | Bull Math Biol | 2026 | 41721174 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related genes in immunity and immunotherapy in diabetic foot ulcer. | Ann Med Surg (Lond) | 2026 | 41675755 | PubTator, text mining | PubMed |
| Identification of ADAR1i-124: The first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential. | iScience | 2026 | 41608661 | PubTator, text mining | PubMed |
| TSniffer: unbiased de novo identification of RNA editing sites and quantification of editing activity in RNA-seq data. | Genome Biol | 2026 | 41549280 | PubTator, text mining | PubMed |
| Activity and dynamics of p110α are not differentially modulated by regulatory subunit isoforms. | Adv Biol Regul | 2026 | 41203468 | PubTator, text mining | PubMed |
| Proline 110 is necessary for maintaining a compact helical arrangement in caveolin-1. | Biophys Chem | 2026 | 41106301 | PubTator, text mining | PubMed |
| Structural investigation of human U6 snRNA recognition by spliceosomal recycling factor SART3 RNA recognition motifs. | FEBS J | 2026 | 41046346 | PubTator, text mining | PubMed |
| Targeted RNA base editing for therapeutic: mechanisms and advances. | Pharm Sci Adv | 2025 | 41550651 | PubTator, text mining | PubMed |
| Epitranscriptome-wide profiling identifies RNA editing events regulated by ADAR1 that are associated with DNA repair mechanisms in human TK6 cells. | Front Genet | 2025 | 41164819 | PubTator, text mining | PubMed |
| Understanding the role of the cytadhesins on the pathogenesis and transmission of Mycoplasma genitalium infection: a minireview. | FEMS Microbiol Lett | 2025 | 40973799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9733/papers